Acid ceramidase (aCDase) is one of several enzymes responsible for ceramide degradation within mammalian cells. As such, aCDase regulates the intracellular levels of the bioactive lipid ceramide. An inherited deficiency of aCDase activity results in Farber disease (FD), also called lipogranulomatosis, which is characterized by ceramide accumulation in the tissues of patients.
Introduction
Farber disease (FD) is a rare inherited lipid storage disorder, also known as lipogranulomatosis, which is characterized by accumulation of ceramide in the cells and tissues of patients (1, 2) . This accumulation is the consequence of a deficient intracellular activity of aCDase, a lysosomal hydrolase encoded by the ASAH1 gene. The main clinical features include painful and progressively deformed joints, subcutaneous nodules, a hoarse cry due to laryngeal involvement, and premature death. Hepatosplenomegaly and nervous system dysfunction may also occur (1, 2) . Although the pathogenesis of FD is still unclear in terms of the molecular lesions caused by ceramide storage, the involvement of aCDase deficiency is undoubtful. Recent interest in aCDase also stems from the fact that this enzyme appears to modulate cell functions by controlling the levels of ceramide and sphingoid bases, which are both considered as putative bioactive molecules (3) .
Diagnosis of FD must be biochemically confirmed by the demonstration of deficient activity of aCDase, which can then be further documented by characterization of the ASAH1 molecular defects. Although aCDase is a very well known enzyme, existing methods for determining its activity and for FD diagnosis still exhibit many disadvantages. The methods that have been used for FD diagnostic purposes can be classified into three groups: (i) aCDase enzymatic assays (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) , classically performed with radiolabelled substrates (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) , which are rather water-insoluble and require at least one detergent (see Table 1 ); (ii) loading tests, consisting in the addition of exogenous radiolabelled sphingolipids, e.g. ceramide (17, 18) , sulfatide (19, 20) (22, 23) or through the use of the diacylglycerol kinase assay in the presence of
![
32 P]ATP to measure the radiolabelled ceramide 1-phosphate produced (24) .
Some of the main drawbacks of these methods are: the use of radiolabelled compounds, most of them being no longer commercially available; the laborious process of separation and identification of reaction products; the need for specific instruments, such as a radiochromatoscanner, HPLC, GC-MS or phosphorimager; the possibility of ceramide breakdown by non-lysosomal ceramidases; the requirement of large quantities of biological material, and the complex incubation mixture in aCDase activity assays. All these disadvantages make both the aCDase assay and the diagnosis of FD restricted to very few expert laboratories.
Recently, our group published a versatile fluorimetric procedure to determine activity of ceramidases by using a synthetic ceramide analogue carrying a 2-oxo-2H-chromen-7-yloxy moiety in the CH 3 -terminal part of the sphingoid chain (25) . This structure enables the release of umbelliferone after ceramidase hydrolysis, periodate oxidation of the resulting aminodiol and further 
Materials and methods

Synthesis of substrates
The Rbm14 substrates were prepared by N-acylation of the coumarinic aminodiol under standard conditions using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, 1-hydroxybenzotriazole, and the fatty acid of choice. The long chain base was prepared as reported (25) from Garner's aldehyde, which was transformed into tert-butyl (4S,2'S)-2,2-dimethyl-4-(oxiran-2-yl)oxazolidine-3-carboxylate as described (26) . Treatment of the resulting epoxide with dimethylsulfonium methylide gave tert-butyl (4S,1'R)-4-(1-hydroxy-2-propenyl)-2,2-dimethyloxazolidine-3-carboxylate, which was hydroborated to
carboxylate. Its primary mesyl ester, prepared by selective mesylation of the primary alcohol, was treated with the umbelliferone salt to give an adduct that afforded the corresponding aminodiol upon removal of the protective groups. Lysosomal "-galactosidase assay
The acid "-galactosidase activity was determined on the same cell lysates used for the measure of aCDase activity. This assay is based on a published fluorimetric method (28) of lysate and 10 µl of ultra pure water. After incubation at 37ºC for 30 min, the reaction was stopped by the addition of 100 µl of a 100 mM glycine/NaOH buffer pH 10.6. The fluorescence released was quantified using a microplate fluorescence reader ($ ex 360 nm, $ em 446 nm) as described above.
Effect of protein amount and incubation time
To determine the time-dependence of Rbm14-12 hydrolysis, the enzyme assay was carried out at different incubation times, ranging from 0.5 to 6 hours. To determine the detection limit of the assay, we used variable amounts of protein extract, from 2.5 to 180 µg. phosphate buffer (pH 6.0 to 8.1) and glycine-NaOH buffer (pH 8.9 to 9.8).
Determination of kinetic constants
Kinetic constants were calculated from Lineweaver-Burk representations of at least 5 aCDase activity assays, using different concentrations of Rbm14-12
(from 2.5 to 80 µM), and in the presence of protein amounts from 10 to 25 µg.
Results
Substrate specificity of acid ceramidase
We tested the synthesized substrates on FD1 and FD1 AcCer10x cell lysates in order to check whether these substrates are hydrolyzed by and specific for aCDase. Under the same incubation conditions, we found that among the seven substrates tested, only four, i.e., Rbm14-10, 12, 14 and 16 were hydrolyzed by lysates of cells overexpressing AcCer (Fig. 1) . These results agree with the previously reported fatty acid chain specificity of aCDase. In addition, the lack of detectable substrate hydrolysis by FD lysates indicates the specificity of these substrates for aCDase. The aCDase specific activity obtained using the already published compound Rbm14-16 showed that, among all the molecules tested, this analog exhibited the lowest affinity for aCDase, whereas Rbm14-12 showed the highest hydrolysis rates, up to 7 times those of the C16 homologue. Taking into account these results, the enzymatic assay for aCDase was optimized using Rbm14-12 as a novel fluorogenic substrate.
Enzyme assay optimization
We investigated the pH dependence of Rbm14-12 hydrolysis in FD1 AcCer10X, but also in FD1 fibroblasts and normal lymphoid cells to further test the substrate specificity for aCDase. Using the FD1 cell line, we found no hydrolysis of the substrate at any pH tested, whereas the FD1 AcCer 10X cells hydrolyzed Rbm14-12 at acidic pH, with optimal activity around pH 6 (Fig. 2) . Normal lymphoid cells showed the same pattern as FD1 AcCer10X fibroblasts but exhibited lower activity levels. Although enzyme activity peaked at pH 6, comparable results, albeit with lower fluorescence intensity values, were obtained at pH 4.5. Therefore, all subsequent assays were performed at pH 4.5 as this is close to the physiological pH in lysosomes and because any possible interference by non-lysosomal ceramidases needs to be avoided for specific determination of aCDase activity and FD diagnosis.
Hydrolysis of Rbm14-12 was dependent on protein concentration. Incubation of the substrate in the presence of different amounts of FD1 AcCer 10X protein extracts, ranging from 2.5 to 180 µg, showed a linear response up to 25 µg of protein, reaching a plateau at 50 µg (Fig. 3A) . Therefore, a 10 to 25 µg quantity was chosen as an optimal protein amount in subsequent aCDase assays. 
Determination of kinetic constants
When the substrate concentration was varied at pH 4.5 under the abovementioned conditions, maximum aCDase activity was observed above 40
µmol/L of substrate with an apparent K m of 25.9 ± 9 µM, and a V max of 334 ± 62 pmol/min/mg (Fig. 3D ).
Acid ceramidase activity in Farber disease cell lines
The optimized assay was then used to determine aCDase activity in a series of FD cell lines, to assess its usefulness for diagnosing FD. Five lines of FD fibroblasts and five lines of FD lymphoid cells were tested. In both cases, the aCDase activity in FD cell lines was very low or undetectable, whereas in control cells specific aCDase activities ranged from 4 to 9 nmol/h mg in fibroblasts and from 8 to 15 nmol/h/mg in lymphoid cells ( Table 2) . As a control for integrity of lysosomal hydrolases in the FD cell lines tested, the activity of acid "-galactosidase was determined. Despite interindividual variations, "- As compared to the previously described methods for diagnosing FD through aCDase assay, the present enzyme assay exhibits many advantages (see also 
